CN105111150B - 一种治疗骨质疏松的药物组合物 - Google Patents
一种治疗骨质疏松的药物组合物 Download PDFInfo
- Publication number
- CN105111150B CN105111150B CN201510598208.2A CN201510598208A CN105111150B CN 105111150 B CN105111150 B CN 105111150B CN 201510598208 A CN201510598208 A CN 201510598208A CN 105111150 B CN105111150 B CN 105111150B
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutical composition
- present
- cell
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510598208.2A CN105111150B (zh) | 2015-09-20 | 2015-09-20 | 一种治疗骨质疏松的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510598208.2A CN105111150B (zh) | 2015-09-20 | 2015-09-20 | 一种治疗骨质疏松的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105111150A CN105111150A (zh) | 2015-12-02 |
CN105111150B true CN105111150B (zh) | 2016-05-11 |
Family
ID=54659305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510598208.2A Expired - Fee Related CN105111150B (zh) | 2015-09-20 | 2015-09-20 | 一种治疗骨质疏松的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105111150B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111214763A (zh) * | 2020-01-07 | 2020-06-02 | 中国科学院深圳先进技术研究院 | 一种节律性光刺激模式***及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2039248A1 (de) * | 2007-09-21 | 2009-03-25 | Bayer CropScience AG | Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften |
DE102007045922A1 (de) * | 2007-09-26 | 2009-04-02 | Bayer Cropscience Ag | Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften |
-
2015
- 2015-09-20 CN CN201510598208.2A patent/CN105111150B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN105111150A (zh) | 2015-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Effendy et al. | The effects of tualang honey on bone metabolism of postmenopausal women | |
CN102355910B (zh) | 利用abh抗原改善炎症性疾病的组合物 | |
EP3615029A2 (en) | Formulations for extending lifespan and healthspan | |
Tao et al. | Dysimmunity and inflammatory storm: watch out for bone lesions in COVID-19 infection | |
CN105111150B (zh) | 一种治疗骨质疏松的药物组合物 | |
CN102078292A (zh) | 生物利用度提高的胶原蛋白口服液 | |
CN103736212A (zh) | 一种基于高频低强振动的骨损伤/骨质疏松治疗床 | |
Urist | THE ETIOLOGY OF OSTEOPOROSIS: GUEST EDITORIAL | |
CN102711783A (zh) | 含有黄芪提取物的、加速新陈代谢的组合物 | |
CN102058567B (zh) | 3′, 4-二羟基-3, 5′-二甲氧基联苄在制备治疗白内障的药物中的应用 | |
CN104478822B (zh) | 一种治疗骨质疏松的药物组合物 | |
CN103877140A (zh) | 雪莲培养物在制备促进骨骼健康产品中的应用 | |
CN111870689A (zh) | 一种纳豆激酶在治疗骨质疏松药物中的应用 | |
CN102770150A (zh) | 用于提高过氧化物酶体增殖物活化受体δ的活性的组合物 | |
CN102389412B (zh) | 一种治疗白内障的滴眼液 | |
CN101837061B (zh) | 山楂叶及其提取物的制药用途 | |
Mikosch | Osteoporosis: pathophysiology and clinical aspects | |
CN103031268B (zh) | OGP-rhLeptin融合蛋白转基因工程菌株 | |
CN104352536A (zh) | 一种治疗骨质疏松的药物组合物 | |
CN105832895A (zh) | 一种治疗骨肉瘤的药物 | |
CN101530482B (zh) | 毛茛总苷在制备治疗心血管疾病药物中的应用 | |
Guay et al. | Primary hyperparathyroidism in osteogenesis imperfecta. | |
CN104800825A (zh) | 从微藻中分离出来的肽通过MAPK和NF-kB诱导成骨细胞分化方法 | |
CN103012598B (zh) | 用于治骨质疏松症和肥胖的OGP-rhLeptin融合蛋白及编码该融合蛋白的核酸 | |
US20190054133A1 (en) | Method for increasing expressions of clock gene, arntl gene, and/or per2 gene by using momordica charantia extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Maoshu Inventor before: Wei Fang |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160418 Address after: Department of orthopedics, the first people's Hospital of Shandong Province, Jining City Health Road 272100 No. 6 North Lake District of Jining City Applicant after: Zhang Maoshu Address before: The Three Gorges in Hebei province Shijiazhuang City Road 052165 Shijiazhuang economic and Technological Development Zone No. 1 Applicant before: Wei Fang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160511 Termination date: 20160920 |